The role of procalcitonin in a decision tree for prediction of bloodstream infection in febrile patients

Clinical Microbiology and Infection

Volumn 12, Issue 12, 2006, Pages 1207-1213

  Peters, R P H ^a   Twisk, J W R ^a   van Agtmael, M A ^a   Groeneveld, A B Johan ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bloodstream infection; CART analysis; Decision tree; Febrile patients; Prediction; Procalcitonin

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; PROCALCITONIN;

ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BREATHING RATE; CONTROLLED STUDY; DECISION THEORY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FEVER; HORMONE BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEPSIS; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT;

EID: 33751077755     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01556.x     Document Type: Article

References (41)

1. Harris RL, Musher DM, Bloom K et.al. Manifestations of sepsis. Arch Intern Med 1987; 147: 1895-1906.
2. Bossink AW, Groeneveld AB, Hack CE, Thijs LG. Prediction of mortality in febrile medical patients: How useful are systemic inflammatory response syndrome and sepsis criteria? Chest 1998; 113: 1533-1544.
3. Bossink AW, Groeneveld AB, Thijs LG. Prediction of microbial infection and mortality in medical patients with fever: Plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables. Clin Infect Dis 1999; 29: 398-407.
4. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244: 379-386.
5. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115: 529-535.
6. Laupland KB, Zygun DA, Doig CJ, Bagshaw SM, Svenson LW, Fick GH. One-year mortality of bloodstream infection-associated sepsis and septic shock among patients presenting to a regional critical care system. Intens Care Med 2005; 31: 213-219.
7. Bates DW, Sands K, Miller E et.al. Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis 1997; 176: 1538-1551.
8. Wang SJ, Kuperman GJ, Ohno-Machado L, Onderdonk A, Sandige H, Bates DW. Using electronic data to predict the probability of true bacteremia from positive blood cultures. In: Overhage MJ, ed., Proceedings of the 2000 AMIA Symposium. Bethesda, MD: AMIA, 2000; 893-897.
9. Aalto H, Takala A, Kautiainen H, Repo H. Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. Eur J Clin Microbiol Infect Dis 2004; 23: 699-704.
10. Jaimes F, Arango C, Ruiz G et al. Predicting bacteremia at the bedside. Clin Infect Dis 2004; 38: 357-362.
11. Pantell RH, Newman TB, Bernzweig J et al. Management and outcomes of care of fever in early infancy. JAMA 2004; 291: 1203-1212.
12. Persson L, Engervall P, Magnuson A et al. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis 2004; 36: 365-371.
13. Metersky ML, Ma A, Bratzler DW, Houck PM. Predicting bacteremia in patients with community-acquired pneumonia. Am J Respir Crit Care Med 2004; 169: 342-347.
14. Isaacman DJ, Shults J, Gross TK, Davis PH, Harper M. Predictors of bacteremia in febrile children 3-36 months of age. Pediatrics 2000; 106: 977-982.
15. Lapillonne A, Basson E, Monneret G, Bienvenu J, Salle BL. Lack of specificity of procalcitonin for sepsis diagnosis in premature infants. Lancet 1998; 351: 1211-1212.
16. Lecharny JB, Khater D, Bronchard R et al. Hyperprocalcitonemia in patients with perioperative myocardial infarction after cardiac surgery. Crit Care Med 2001; 29: 323-325.
17. Chirouze C, Schuhmacher H, Rabaud C et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis 2002; 35: 156-161.
18. Hensler T, Sauerland S, Lefering R et al. The clinical value of procalcitonin and neopterin in predicting sepsis and organ failure after major trauma. Shock 2003; 20: 420-426.
19. Nylen E, Muller B, Becker KL, Snider R. The future diagnostic role of procalcitonin levels: The need for improved sensitivity. Clin Infect Dis 2003; 36: 823-824.
20. van Dissel JT. Procalcitonin: What should be its role in the clinical management of febrile patients admitted to the hospital? Clin Infect Dis 2003; 36: 824-825.
21. Clec'h C, Ferriere F, Karoubi P et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004; 32: 1166-1169.
22. Muller B, Christ-Crain M, Nylen ES, Snider R, Becker KL. Limits to the use of procalcitonin level as a diagnostic marker. Clin Infect Dis 2004; 39: 1867-1868.
23. Munoz P, Simarro N, Rivera M, Alonso R, Alcala L, Bouza E. Evaluation of procalcitonin as a marker of infection in a nonselected samples of febrile hospitalized patients. Diagn Microbiol Infect Dis 2004; 49: 237-241.
24. Aikawa N, Fujishima S, Endo S et.al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 2005; 11: 152-159.
25. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clin Infect Dis 2004; 39: 206-217.
26. Christ-Crain M, Jaccard-Stolz D, Bingisser R et.al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial. Lancet 2004; 363: 600-607.
27. Marc E, Menager C, Moulin F et.al. Procalcitonin and viral meningitis: reduction of unnecessary antibiotics by measurement during an outbreak. Arch Pediatr 2002; 9: 358-364.
28. von Lilienfeld-Toal M, Dietrich MP, Glasmacher A et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: Procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis 2004; 23: 539-544.
29. Hausfater P, Garric S, Ayed SB, Rosenheim M, Bernard M, Riou B. Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: A prospective study. Clin Infect Dis 2002; 34: 895-901.
30. Bell K, Wattie M, Byth K et al. Procalcitonin: A marker of bacteraemia in SIRS. Anaesth Intens Care 2003; 31: 629-636.
31. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003; 31: 1737-1741.
32. Giamarellou H, Giarmarrellos-Bourboulis EJ, Repoussis P et al. Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicenter study. Clin Microbiol Infect 2004; 10: 628-633.
33. Thayyil S, Shenoy M, Hamaluba M, Gupta A, Frater J, Verber IG. Is procalcitonin useful in early diagnosis of serious bacterial infections in children? Acta Paediatr 2005; 94: 155-158.
34. Tokuda Y, Miyasato H, Stein GH. A simple prediction algorithm for bacteremia in patients with acute febrile illness. Q J Med 2005; 98: 813-820.
35. Thwaites GE, Chau TT, Stepniewska K et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 2002; 360: 1287-1292.
36. Bhavnani SM, Drake JA, Forrest A et.al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis 2000; 36: 145-158.
37. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36: 1418-1423.
38. Bachur RG, Harper MB. Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics 2001;108: 311-316.
39. Breiman L, Friedman JH, Olshen RA, Stone CJ, eds, Classification and regression trees. New York: Chapman & Hall, 1984.
40. Lemon SC, Roy J, Clark MA, Friedman PD, Rakowski W. Classification and regression tree analysis in public health: Methodological review and comparison with logistic regression. Ann Behav Med 2003; 26: 172-181.
41. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-1330.